ALMKT:EPA
Mauna Kea Technologies SA
€0.092
0.00%
(0.00) 1D
ኖቬም 13, 5:35:01 ከሰዓት ጂ ኤም ቲ+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€0.09
High
€0.10
Low
€0.09
Mkt. cap
18.14 ሚ
Avg. vol.
541.14 ሺ
Volume
75.16 ሺ
P/E ratio
0.79
52-wk high
€0.23
52-wk low
€0.07
EPS
€0.12
Shares outstanding
195.26 ሚ
No. of employees
56
Open
€0.09
High
€0.10
Low
€0.09
Mkt. cap
18.14 ሚ
Avg. vol.
541.14 ሺ
Volume
75.16 ሺ
P/E ratio
0.79
52-wk high
€0.23
52-wk low
€0.07
EPS
€0.12
Shares outstanding
195.26 ሚ
No. of employees
56
News stories
From web sources and news partners
TradingKey
·
ከ3 ሰዓቶች በፊት
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
ከ11 ሰዓቶች በፊት
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
ከ6 ሰዓቶች በፊት
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
ከ10 ሰዓቶች በፊት
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees56
Founded2000
Headquarters-
SectorHealth Care
IndustryMedical device
Websitemaunakeatech.com